• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

OMRF is an independent, nonprofit biomedical research institute dedicated to discoveries that make a difference.

  • About
    • General Information
    • Disease Research
    • Education & Outreach
    • Events
    • Jobs
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • OMRF in the Media
    • OMRF News
    • OMRF Publications
    • OMRF Videos
    • Dr. Prescott’s Columns
  • Patients
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Syndrome
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Tax Credit
    • Planned Giving
    • Vehicle Donations
    • Why We Give
    • Your Gift at Work
    • Donor Recognition
    • Contact
Home - OMRF News - Archives for sickle cell

sickle cell

OMRF drug ‘a blessing’ for sickle cell patient

January 11, 2021

Adakveo, a drug based on the discoveries of OMRF VP of Research Rodger McEver, is relieving pain for Danielle Jamison and others with sickle cell around the world.

Filed Under: News Tagged With: anemia, antibody, blood, danielle, disease, disorder, drug, jamison, McEver, medicine, news, newsok, OKC, Oklahoma, Oklahoma Medical Research Foundation, oklahoman, OMRF, pain, rodger, scientist-news, sickle cell, therapy, treatment

A Sickle Cell Milestone

New drug with OMRF roots reduces pain in sickle cell disease.

FDA approves new sickle cell drug with Oklahoma roots

November 18, 2019

Adakveo significantly reduces pain crises in sickle cell patients.

Filed Under: News, Technology Ventures News Tagged With: Adakveo, FDA, FDA approval, McEver, novartis, P-selectin, pain crises, rodger, Rodger McEver, scd, scientist-news, selexys, sickle cell, sickle cell disease

New hope in the fight against sickle cell disease

June 14, 2018

For Mary Long, the answer to her pain may, literally, be right around the corner.

Filed Under: News Tagged With: biology, biotechnology, blood, cell, disease, drug, mary long, McEver, news, newsok, novartis, OKC, Oklahoma Medical Research Foundation, OMRF, option, P-selectin, pain, patients, rodger, Rodger McEver, scd, scientist-news, selexys, sickle cell, therapy

McEver, Rodger P.

Before Footer

EEO/AA Employer/Vet/Disabled

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Intranet
Charity navigator
United Way Give Smart OKC
Facebook Twitter YouTube Instagram Mail Linkedin
Administrator Log In